CADTH Reimbursement Recommendation Tisagenlecleucel (Kymriah) - Indication: For the treatment of adult patients with relapsed or refractory grade

If your institution is a member, please log into Canada Commons from a link provided by your institution. This typically involves logging in via a menu managed by your library.

Accessing this content requires a membership

If your institution is a member, please log into Canada Commons from a link provided by your institution. This typically involves logging in via a menu managed by your library.